131 results
Page 4 of 7
8-K
EX-99.1
4lf1la92znj5m7cj0z
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
fsqe2nyn4yhlm mx1p
24 Jun 20
Business combination disclosure
4:03pm
425
gueb1yde 6zvayzdl
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.4
4ya j9x8lk
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.2
4f5y8
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
8utgy1l0kx3xsew3m
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
a2uqla2g6brb71
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
34294
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
S-3ASR
8revz982rg9qoyys6jd1
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
8jtkcwl2tdgmlo
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-99.2
gvo5jo
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.1
bbufbykq4 y6bikjiiig
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
hhnn8d4 5brs6v99tn0
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
dli6wg3k jxqsvm
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-99.1
55jl4u
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
xhjm6za2046ifhk6i
18 Mar 20
Automatic shelf registration
10:00pm